Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Nicotinamide; Pyridoxine hydrochloride; Riboflavin; Thiamine hydrochloride
Accord-UK Ltd
Nicotinamide; Pyridoxine hydrochloride; Riboflavin; Thiamine hydrochloride
20mg ; 2mg ; 2mg ; 5mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09060207; GTIN: 5012617010605
148x210 Leaflet Reel Fed Profile (BST) Dimensions: Component: Date Sent: Technologist: TECHNICALLY APPROVED Pharmacode: JDE No.: Vitamin B Compound Strong 28 x Film-coated Tablets (UK) 148x210 (Reel Fed) 50993872 Leaflet for Blisters 4517 T. Hull 04/09/2020 approved for print/date PROOF ROUND Technical Approval DATE SENT: DATE RECEIVED: Item number: ORIGINATOR: ORIGINATION DATE: REVISION DATE: REVISED BY: DIMENSIONS: MIN BODY TEXT SIZE: SUPPLIER: NON PRINTING COLOURS COLOURS 1. 2. 3. 4. 5. 6. 1. 2. 3. EU-Artwork-Support@accord-healthcare.com M.Doak 18/09/2020 148x210mm 9pt Accord Barnstaple N/A N/A VITAMIN B 28 TABLETS PIL - UK Black Profile BBBA9009 1 * Please note that ONLY Artwork Studio is permitted to make changes to the above artwork. No changes are permitted by any 3rd party other than added notes and mark ups for required changes. Version 7 12.02.2020 Cartons and label leaflets only (labels only when specified) German GTIN 14 (incorporating PZN): N/A Vitamin B Compound Strong Film-coated Tablets READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. • You must talk to a doctor if you do not feel better or if you feel worse. • The full name of this medicine is Vitamin B Compound Strong Film-coated Tablets but within this leaflet it will be referred to as Vitamin B Compound Strong Tablets. WHAT IS IN THIS LEAFLET 1 WHAT VITAMIN B COMPOUND STRONG TABLETS ARE AND WHAT THEY ARE USED FOR 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE VITAMIN B COMPOUND STRONG TABLETS 3 HOW TO TAKE VITAMIN B COMPOUND STRONG TABLETS 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE VITAMIN B COMPOUND STRO Read the complete document
OBJECT 1 VITAMIN B COMPOUND STRONG TABLETS Summary of Product Characteristics Updated 14-May-2020 | Accord-UK Ltd • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product VITAMIN B COMPOUND STRONG FILM-COATED TABLETS 2. Qualitative and quantitative composition Each tablet contains 20mg Nicotinamide, 2mg Pyridoxine Hydrochloride, 2mg Riboflavine, 4.85mg Thiamine Mononitrate. Also contains lactose. For a full list of excipients, see section 6.1 3. Pharmaceutical form Film-coated tablet (tablet). Brown, circular, biconvex film-coated tablets with the identifying letters “VB” embossed on one side. 4. Clinical particulars 4.1 Therapeutic indications 1) For the treatment of clinical and sub-clinical vitamin B deficiency states (manifestations of which include glossitis, stomatitis, cheilosis, the heart manifestations of beriberi, the skin manifestations of pellagra, corneal vascularisation and polyneuritis). 4.2 Posology and method of administration _Adults (including elderly) and Read the complete document